title: Growth in boys with idiopathic nephrotic syndrome on long-term cyclosporin and steroid treatment.
abstract: Although steroid-free remission can usually be achieved with cyclosporin A (CsA) in patients with steroid-dependent nephrotic syndrome (SDNS), some CsA-treated patients require long-term steroid therapy. Data on growth in these patients are scarce. Sixty-four boys with SDNS receiving long-term CsA and steroid therapy were retrospectively analyzed. During the 10-year follow-up period, height standard deviation score (HSDS) remained in the normal range in 47 patients but was below -2 SD in 17 patients. The occurrence of growth retardation was influenced by height at diagnosis and the number of relapses. Thirty patients were followed for at least 3 years before and after age 12. The decrease in HSDS per year of disease in patients older than 12 years was twice that observed in children younger than 12. However, adult height was < or = -2 SD in only two of the 14 patients reaching adult height, reflecting potential catch-up growth during late puberty. Careful monitoring of growth is recommended, given than up to 25% of patients experienced severe growth retardation during the course of their disease.
authors: Assistance publique-Hôpitaux de Paris, Hôpital Robert Debré, Service de Néphrologie Pédiatrique, Paris, France. valerie.leroy@unige.ch
authors: Valérie
authors: V
authors: Leroy
authors: Véronique
authors: V
authors: Baudouin
authors: Corinne
authors: C
authors: Alberti
authors: Geneviève
authors: G
authors: Guest
authors: Patrick
authors: P
authors: Niaudet
authors: Chantal
authors: C
authors: Loirat
authors: Georges
authors: G
authors: Deschenes
authors: Paul
authors: P
authors: Czernichow
authors: Dominique
authors: D
authors: Simon
mesh_terms: D000328:Adult; D001827:Body Height; D002675:Child, Preschool; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006128:Growth / Q000502:physiology*; D006130:Growth Disorders / Q000139:chemically induced; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008137:Longitudinal Studies; D008297:Male; D009404:Nephrotic Syndrome / Q000188:drug therapy*; D012008:Recurrence; D012189:Retrospective Studies; D013256:Steroids / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D013256:Steroids; D016572:Cyclosporine